Resource Central is a product of the Pediatric Pandemic Network.

Nirsevimab Library

This is a collection of current resources related to Nirsevimab.

1120 of over 100 results
Cost-Effectiveness of Maternal Vaccination to Prevent Respiratory Syncytial Virus Illness
2024 · University of Michigan, · Centers for Disease Control and Prevention (CDC), · U.S. Public Health Service
This study evaluates the benefits and cost-effectiveness of a vaccine for pregnant women to protect babies from RSV, a virus that can cause serious illness …
Nirsevimab Coverage, Children 0 to 7 months, United States
2025 · Centers for Disease Control and Prevention (CDC)
The report describes how nirsevimab coverage for infants 0 to 7 months is tracked in the U.S. using data from Immunization Information Systems (IIS). It …
Notes from the Field: Rollout of Nirsevimab to Protect Infants and Young Children During the Respiratory Syncytial Virus Season — New York City, 2023–2024
2024 · New York City Department of Health and Mental Hygiene, · Centers for Disease Control and Prevention (CDC)
This analysis reviewed nirsevimab dosing based on Vaccines for Children (VFC) eligibility in New York City during the 2023–24 RSV season. A nirsevimab shortage in …
Recommended Childhood and Adolescent Immunization Schedule: United States, 2024
2024 · American Academy of Pediatrics (AAP)
This policy statement describes the 2024 recommended childhood and adolescent immunization schedules, approved by multiple medical organizations including the CDC and AAP. Updates include the …
Use of the Pfizer Respiratory Syncytial Virus Vaccine During Pregnancy for the Prevention of Respiratory Syncytial Virus-Associated Lower RespiratoryTract Disease in Infants: Recommendations of the Advisory Committee on Immunization Practices - United Sta
2023 · Centers for Disease Control and Prevention (CDC)
This article discusses the use of Pfizer's RSV vaccine for pregnant women to protect infants from RSV-related lung disease. The CDC recommends giving the vaccine …
Indian Health Service Nirsevimab Vaccine Update
2024 · Indian Health Service
This document provides information on nirsevimab and recommendations for its use, including an administration visual guide. It addresses the documentation of administered doses and reconciliation …
Veterans Health Library: Nirsevimab-alip
2025 · American Society of Health-System Pharmacists (ASHP), · U.S. Department of Veterans Affairs
This webpage provides drug information for Nirsevimab-alip (Brand Name: Beyfortus®). It addresses why and how it is used, special precautions, dietary instructions, and side effects.
MedlinePlus: Nirsevimab-alip
2024 · American Society of Health-System Pharmacists (ASHP), · U.S. Department of Health and Human Services (HHS)
This webpage provides drug information on nirsevimab-alip (brand name: Beyfortus®). It addresses why and how it should be used, special precautions, and side effects.
Nirsevimab Administration Visual Guide
2024 · American Academy of Pediatrics (AAP)
This 2-page infographic includes a flowchart to aid in making decisions about nirsivemab administration and dosing in infants and toddlers. It provides immunization administration tips, …
Drug Trials Snapshots: BEYFORTUS
2024 · U.S. Food and Drug Administration
This webpage features a drug trial snapshot for the drug Beyfortus, a monoclonal antibody given as an injection to protect against RSV. Snapshots reveal participants …

Looking for different way to find resources?

Our chatbot aRCie can help with a more personalized search. Click below to try our new chatbot.

Try aRCie
1120 of over 100 results